Business

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Bagsværd, Denmark, 11 February 2026 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have reported the transactions to Novo Nordisk. 1 Details of the person discharging managerial responsibilities/person closely associated a)Name of the

articleNovo Nordisk A/s Class BFebruary 11, 20262/company/novo-nordisk-as-class-b/news/novo-nordisk-as-trading-in-novo-nordisk-shares-by-board-members-executives-and-associated-persons
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

About this update from Novo Nordisk A/s Class B

[{"type":"image","alt":"Novo Nordisk A/S","displaySize":"","headline":null,"caption":"Novo Nordisk A/S","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":214,"url":"https://media.zenfs.com/en/globenewswire.com/b199128d4b2bbea4504ed4a2f3b29b4e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Sq36MpNFOiz.w6RiXrpsqg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTMwMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/b199128d4b2bbea4504ed4a2f3b29b4e","width":300,"height":214},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/Sq36MpNFOiz.w6RiXrpsqg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTMwMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/b199128d4b2bbea4504ed4a2f3b29b4e","width":300,"height":214}},"lazy":false},{"type":"text","content":"Bagsværd, Denmark, 11 February 2026 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have reported the transactions to Novo Nordisk.","length":395,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"width:28.4px;border-top:solid black 1pt;border-right:solid black 1pt;border-bottom:solid black 1pt;border-left:solid black 1pt;vertical-align:top;","val":[{"type":"text","content":"1 ","length":1,"tagName":"p","attribs":{}}]},{"colspan":"6","style":"width:569.27px;border-top:solid black 1pt;border-right:solid black 1pt;border-bottom:solid black 1pt;vertical-align:top;","val":[{"type":"text","content":"Details of the person discharging managerial responsibilities/person closely associated ","length":87,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:28.4px;border-right:solid black 1pt;border-bottom:solid black 1pt;border-left:solid black 1pt;vertical-align:top;","val":[{"type":"text","content":"a)","length":2,"tagName":"p","attribs":{}}]},{"style":"width:293.74px;border-right:solid black 1pt;border-bottom:solid black 1pt;vertical-align:top;","val":[{"type":"text","content":"Name of the Board member/Executive/Associated Person","length":52,"tagName":"p","attribs":{}}]},{"colspan":"4","style":"width:273.27px;border-right:solid black 1pt;border-bottom:solid black 1pt;vertical-align:top;","val":[{"type":"tex...

More updates from Novo Nordisk A/s Class B

Novo NordiskInitial notificationtransactionJacob Martin